Thomas Kruse
40Patents
6h-index
60Co-inventors
72Inventor score
Filing activity: Jul 16, 1999 → Nov 17, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8895694B2 | Glucagon-Like Peptide-1 derivatives and their pharmaceutical use | Human Necessities | 24 | Active |
| US10005827B2 | Double-acylated GLP-1 derivatives | Human Necessities | 22 | Active |
| US9006178B2 | Double-acylated GLP-1 derivatives with a linker | Human Necessities | 16 | Active |
| US9067977B2 | Peptides derivatized with A-B-C-D- and their therapeutical use | Human Necessities | 16 | Active |
| US8575090B2 | Amylin analogues and pharmaceutical compositions thereof | Human Necessities | 13 | Active |
| US9708383B2 | Double-acylated GLP-1 derivatives | Human Necessities | 10 | Active |
| US9023789B2 | Amylin analogs and pharmaceutical compositions thereof | Chemistry; Metallurgy | 6 | Active |
| US8741836B2 | Polypeptides | Human Necessities | 6 | Active |
| US8232242B2 | Treatment of inflammatory bowel diseases with mammal beta defensins | Human Necessities | 5 | Active |
| US8722849B2 | Polypeptides | Human Necessities | 5 | Active |
| US8895504B2 | Amylin derivatives | Human Necessities | 5 | Active |
| US8541368B2 | Glucagon analogues | Human Necessities | 5 | Active |
| US11117947B2 | Double-acylated GLP-1 derivatives | Human Necessities | 5 | Active |
| US8232248B2 | Treatment of rheumatoid arthritis with mammal beta defensins | Human Necessities | 5 | Active |
| US9279010B2 | Treatment of inflammatory bowel diseases with mammal beta defensins | Human Necessities | 4 | Active |
| US9409966B2 | Glucagon-like peptide-1 derivatives and their pharmaceutical use | Human Necessities | 4 | Active |
| US8575091B1 | Amylin analogues and pharmaceutical compositions thereof | Chemistry; Metallurgy | 4 | Active |
| US8802621B2 | Treatment of inflammatory bowel diseases with mammal beta defensins | Human Necessities | 4 | Active |
| US11034746B2 | Double-acylated GLP-1 derivatives | Human Necessities | 4 | Active |
| US8835379B2 | Derivatives of CGRP | Human Necessities | 3 | Active |
| US9732137B2 | Semi-recombinant preparation of GLP-1 analogues | Chemistry; Metallurgy | 3 | Active |
| US6919315B1 | Compounds with growth hormone releasing properties | Human Necessities | 3 | Expired |
| US11186595B2 | Glucose-sensitive albumin-binding derivatives | Physics | 2 | Active |
| US9486505B2 | Glucagon analogues | Human Necessities | 2 | Active |
| US9593149B2 | Amylin and calcitonin receptor agonist | Human Necessities | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.